Natural History of Non-Functioning Pituitary Adenomas: A Systematic Review and Meta-Analysis
Hormone and Metabolic Research · 01.07.2023 · 55 (07) · 443-451
DOI: 10.1055/a-2096-1340 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.07.2023. Verfasst von Stefan Dukanovic Rikvold und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Adenoma. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
The management of non-functioning pituitary tumors (NFPTs) relies on the risk of tumor growth and new endocrinopathies. The objective of this systematic review was to assess the risk of growth, new pituitary endocrinopathies, and surgery in patients with conservatively treated NFPTs. We conducted a bibliographical search identifying studies assessing NFPTs followed conservatively. Estimates were pooled using random-effects meta-analysis reporting events per 100 person years (PYs), in case of high heterogeneity (I2>75%) only the range of observed effects was reported. We identified 30 cohort studies including 1957 patients with a mean follow-up time of 4.0 (SD 1.5) years. The overall risk of tumor growth ranged from 0.0 to 14.2/100 PYs (I2=90%), while the overall risk of new endocrinopathies was 0.9/100 PYs (95% CI. 0.5 to 1.2; I2=35%) and risk of surgery ranged from 0.0 to 7.7/100 PYs (I2=80%). Compared to microadenomas, macroadenomas had higher risk of growth (p=0.002), higher risk of surgery (p=0.006), and non-significant differences in risk of new endocrinopathies (p=0.15). An analysis of microadenomas found the risk of growth to be 1.8/100 PYs (95% CI. 0.9 to 2.8; I2=58%), the risk of new endocrinopathies 0.7/100 PYs (95% CI. 0.0 to 1.6; I2=37%) and the risk of surgery 0.5/100 PYs (0.1 to 0.9; I2=37%). These data support individualized follow-up strategies of patients with NFPTs and particularly a less rigorous follow-up of patients with microadenomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Medicine, Clinic for Pituitary Disorders, Zealand University Hospital - Koge, Denmark.
Zitieren
APA
Rikvold, S. D., Pedersen, M. B., Andreassen, M., & Krogh, J. (2023). Natural History of Non-Functioning Pituitary Adenomas: A Systematic Review and Meta-Analysis. Hormone and Metabolic Research, 55(07), 443-451. https://doi.org/10.1055/a-2096-1340
Vancouver
Rikvold SD, Pedersen MB, Andreassen M, Krogh J. Natural History of Non-Functioning Pituitary Adenomas: A Systematic Review and Meta-Analysis. Hormone and Metabolic Research. 2023;55(07):443-451. doi:10.1055/a-2096-1340
BibTeX
@article{Rikvold2023,
author = {Rikvold, Stefan Dukanovic and Pedersen, Mathias Brown and Andreassen, Mikkel and Krogh, Jesper},
title = {Natural History of Non-Functioning Pituitary Adenomas: A Systematic Review and Meta-Analysis},
journal = {Hormone and Metabolic Research},
year = {2023},
volume = {55},
number = {07},
pages = {443--451},
doi = {10.1055/a-2096-1340}
}
EUVIMED